股票/基金 实时行情 股吧

简称:恒瑞医药 代码:600276


会计年度:2004-09-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
抗感染药198,838,191.6952,444,432.18146,393,759.5173.62
抗肿瘤药427,533,146.0839,050,162.41388,482,983.6790.87
其他药品165,423,069.8148,517,778.71116,905,291.1070.67

会计年度:2004-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
滴眼液342,399.1930,879.41311,519.7890.98
胶囊剂7,065,689.501,702,054.855,363,634.6575.91
片剂123,989,381.8429,881,584.9794,107,796.8775.90
原料药24,092,038.489,028,432.5415,063,605.9462.53
针剂359,087,667.8746,341,516.72312,746,151.1587.09

会计年度:2003-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂244,045,515.4881,247,401.94162,798,113.5466.71
其他11,144,032.872,225,787.168,918,245.7180.03
医药包装材料218,167,805.14166,564,747.4551,603,057.6923.65
原料药45,236,775.2324,439,336.5720,797,438.6645.97
针剂531,758,182.8973,716,629.32458,041,553.5786.14

会计年度:2003-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂132,912,049.6348,404,226.8084,507,822.8363.58
医药包装材料119,273,231.5588,143,769.7431,129,461.8126.10
原料药20,039,360.6710,216,454.649,822,906.0349.02
针剂223,796,920.1836,743,271.06187,053,649.1283.58

会计年度:2002-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计756,025,400.00581,707,900.00--23.05
片剂249,457,600.00249,457,600.00----
医药包装材料174,317,400.00------
原料药31,532,900.0031,532,900.00----
针剂300,717,300.00300,717,300.00----

    7/8 转到